Antithrombotic therapy for venous thromboembolism in myeloproliferative neoplasms

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2044-5385

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Antithrombotic therapy for venous thromboembolism in myeloproliferative neoplasms ; volume:8 ; number:7 ; day:26 ; month:6 ; year:2018 ; pages:1-7 ; date:7.2018
Blood cancer journal ; 8, Heft 7 (26.6.2018), 1-7, 7.2018

Creator: De Stefano, Valerio

Contributor: Finazzi, Guido
Barbui, Tiziano
SpringerLink (Online service)

DOI: 10.1038/s41408-018-0101-8

URN: urn:nbn:de:101:1-2018090218182705765657

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:24 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

De Stefano, Valerio
Finazzi, Guido
Barbui, Tiziano
SpringerLink (Online service)

Other Objects (12)

Trends and Inpatient Outcomes of Venous Thromboembolism-Related Admissions in Patients with Philadelphia-Negative Myeloproliferative Neoplasms

Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19

Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms

Targeted therapies for myeloproliferative neoplasms

Esophageal lesions in myeloproliferative neoplasms

Novel therapeutics in myeloproliferative neoplasms

Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms

Hochschulschrift

New mouse models of myeloproliferative neoplasms

Aufsatzsammlung

Myeloproliferative neoplasms : critical concepts and management

SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms

Molecular pathogenesis of the myeloproliferative neoplasms

Trends and Inpatient Outcomes of Venous Thromboembolism-Related Admissions in Patients with Philadelphia-Negative Myeloproliferative Neoplasms

Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19

Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms

Targeted therapies for myeloproliferative neoplasms

Esophageal lesions in myeloproliferative neoplasms

Novel therapeutics in myeloproliferative neoplasms

Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms

Hochschulschrift

New mouse models of myeloproliferative neoplasms

Aufsatzsammlung

Myeloproliferative neoplasms : critical concepts and management

SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms

Molecular pathogenesis of the myeloproliferative neoplasms

Trends and Inpatient Outcomes of Venous Thromboembolism-Related Admissions in Patients with Philadelphia-Negative Myeloproliferative Neoplasms

Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19

Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms

Targeted therapies for myeloproliferative neoplasms

Esophageal lesions in myeloproliferative neoplasms

Novel therapeutics in myeloproliferative neoplasms

Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms

Hochschulschrift

New mouse models of myeloproliferative neoplasms

Aufsatzsammlung

Myeloproliferative neoplasms : critical concepts and management

SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms

Molecular pathogenesis of the myeloproliferative neoplasms

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Antithrombotic therapy for venous thromboembolism in myeloproliferative neoplasms

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Trends and Inpatient Outcomes of Venous Thromboembolism-Related Admissions in Patients with Philadelphia-Negative Myeloproliferative Neoplasms

Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19

Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms

Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms

Targeted therapies for myeloproliferative neoplasms

Esophageal lesions in myeloproliferative neoplasms

Novel therapeutics in myeloproliferative neoplasms

Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms

New mouse models of myeloproliferative neoplasms

Myeloproliferative neoplasms : critical concepts and management

SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms

Molecular pathogenesis of the myeloproliferative neoplasms

Trends and Inpatient Outcomes of Venous Thromboembolism-Related Admissions in Patients with Philadelphia-Negative Myeloproliferative Neoplasms

Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19

Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms

Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms

Targeted therapies for myeloproliferative neoplasms

Esophageal lesions in myeloproliferative neoplasms

Novel therapeutics in myeloproliferative neoplasms

Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms

New mouse models of myeloproliferative neoplasms

Myeloproliferative neoplasms : critical concepts and management

SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms

Molecular pathogenesis of the myeloproliferative neoplasms

Trends and Inpatient Outcomes of Venous Thromboembolism-Related Admissions in Patients with Philadelphia-Negative Myeloproliferative Neoplasms

Among classic myeloproliferative neoplasms, essential thrombocythemia is associated with the greatest risk of venous thromboembolism during COVID-19

Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms

Renal disease associated with myeloproliferative neoplasms and myelodysplastic syndrome/myeloproliferative neoplasms

Targeted therapies for myeloproliferative neoplasms

Esophageal lesions in myeloproliferative neoplasms

Novel therapeutics in myeloproliferative neoplasms

Renal post-mortem findings in myeloproliferative and myelodysplastic/myeloproliferative neoplasms

New mouse models of myeloproliferative neoplasms

Myeloproliferative neoplasms : critical concepts and management

SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms

Molecular pathogenesis of the myeloproliferative neoplasms

Related objects

Reset password